Synergistic effect of gefitinib and rofecoxib in mesothelioma cells

BACKGROUND: Malignant mesothelioma (MM) is an aggressive tumor that is resistant to conventional modes of treatment with chemotherapy, surgery or radiation. Research into the molecular pathways involved in the development of MM should yield information that will guide therapeutic decisions. Epiderma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Stoppoloni, Daniela, Canino, Claudia, Cardillo, Irene, Verdina, Alessandra, Baldi, Alfonso, Sacchi, Ada, Galati, Rossella
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2010
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828989/
https://ncbi.nlm.nih.gov/pubmed/20122271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-27
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares